Specifically, increases in protein levels of System L amino acid transporter LAT1 and regulator mTOR, as well as changes in subcellular localization of ASCT2 protein were observed in PE and IUGR, compared to full- and pre-term normal pregnancy controls. The gene discussed is SLC1A5; the disease is fetal growth restriction.